DARWIN EU® - A RWD study to evaluate drug utilisation of Long-acting Insulin analogues and Neutral Protamine Hagedorn Insulin in clinical practice

Study summary

No information provided.

Study identification

• EU PAS number:
  EUPAS1000001135
• Study ID:
  1000001135
• Official title and acronym:
  DARWIN EU® - A RWD study to evaluate drug utilisation of Long-acting Insulin analogues and Neutral Protamine Hagedorn Insulin in clinical practice
• DARWIN EU® study:
  Yes
• Study countries:
  Croatia

  Denmark

  France

  Germany

  Lithuania

  Spain

  Sweden

  United Kingdom
• Study description:
  No information provided.
• Study status:
  Ongoing

Study timelines

Date when funding contract was signed

Planned:30/07/2026

Actual:30/07/2026

Study start date

Planned:25/09/2026

Actual:25/09/2026

Date of final study report

Planned:18/01/2027

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable